Guanxinning tablet for patients who switch from dual antiplatelet therapy to aspirin alone after percutaneous coronary intervention: study protocol for a cluster randomized controlled trial

BACKGROUND: One-year dual antiplatelet therapy (DAPT), generally aspirin in combination with a P2Y12 receptor inhibitor, has been a standard treatment for patients undergoing percutaneous coronary intervention (PCI). Prolonged DAPT has proven itself effective in further reducing cardiovascular event...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jingen, Ju, Jianqing, Chen, Zhuo, Liu, Jing, Lu, Fang, Gao, Rui, Xu, Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5804066/
https://www.ncbi.nlm.nih.gov/pubmed/29415754
http://dx.doi.org/10.1186/s13063-017-2373-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5804066/
https://www.ncbi.nlm.nih.gov/pubmed/29415754
http://dx.doi.org/10.1186/s13063-017-2373-x

Ejemplares similares